XML 41 R34.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Summary of Significant Accounting Policies - Additional Information (Detail)
 6 Months Ended
Jun. 30, 2024
Summary Of Significant Accounting Policies [Line Items]  
Cash, cash equivalents and restricted cash, maturity period three months or less
Accounting Standards Update 2023-09 [Member]  
Summary Of Significant Accounting Policies [Line Items]  
Change in accounting principle, accounting standards update, adopted true
Accounting Standards Update 2023-07 [Member]  
Summary Of Significant Accounting Policies [Line Items]  
Change in accounting principle, accounting standards update, adopted true
Anelixis Therapeutics, LLC and Otic Pharma, Ltd.  
Summary Of Significant Accounting Policies [Line Items]  
Ownership interest percentage 100.00%
Otic Pharma, Inc. [Member]  
Summary Of Significant Accounting Policies [Line Items]  
Ownership interest percentage 100.00%